- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03200535
Comparison of Outreach Methods to Encourage Enrollment in Diabetes Prevention and Weight Management Programs
November 21, 2019 updated by: Emily Schroeder, Kaiser Permanente
Individuals with prediabetes are at increased risk for developing diabetes.
Higher hemoglobin A1c's (6.1-6.4%) are associated with a high risk of developing diabetes.
It is known that programs such weight management classes and one-on-one counseling with registered dieticians can lead to weight loss and decrease the risk of diabetes.
However, engagement of Kaiser Permanente Colorado members in these activities is low.
The purpose of this study is to determine which of three outreach methods is most effective in increasing engagement in these activities.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
6588
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Denver, Colorado, United States, 80014
- Kaiser Permanente Coloado
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Kaiser Permanente Member
- Age 18-75
- Prediabetes
- BMI >= 25
- A1c 6.1-6.4%
- No dietitian visit within the past 3 years
Exclusion Criteria:
- Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Usual care
|
|
|
Active Comparator: Electronic health record "gaps"
Gaps will appear in the electronic health record and patient portal in order to prompt referral by provider or patient
|
Gaps will appear in the electronic health record and patient portal in order to prompt referral by provider or patient
|
|
Active Comparator: Bulk outreach
Gaps will appear in the electronic health record and patient portal in order to prompt referral by provider or patient; in addition a bulk letter or email will be sent
|
Gaps will appear in the electronic health record and patient portal in order to prompt referral by provider or patient
A bulk letter or email will be sent
|
|
Active Comparator: Personalized outreach
Gaps will appear in the electronic health record and patient portal in order to prompt referral by provider or patient; in addition a bulk letter or email will be sent and patients will receive a personalized call by a registered dietitian
|
Gaps will appear in the electronic health record and patient portal in order to prompt referral by provider or patient
A bulk letter or email will be sent
Patients will receive a personalized call by a registered dietitian
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Enrollment in Diabetes Prevention or Weight Management Class (Online)
Time Frame: 4.5 months (6/26/2017-11/10/2017)
|
Percent of individuals who have enrolled in online diabetes prevention or weight management classes (online) over a 4.5 month period
|
4.5 months (6/26/2017-11/10/2017)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Enrollment in Diabetes Prevention or Weight Management Class (in Person)
Time Frame: 4.5 months (6/26/2017-11/10/2017)
|
Percent of individuals who have enrolled in diabetes prevention or weight management class (in person) over a 4.5 month follow-up period
|
4.5 months (6/26/2017-11/10/2017)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Emily Schroeder, MD, PhD, Kaiser Permanente
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 26, 2017
Primary Completion (Actual)
November 10, 2017
Study Completion (Actual)
November 10, 2017
Study Registration Dates
First Submitted
June 23, 2017
First Submitted That Met QC Criteria
June 23, 2017
First Posted (Actual)
June 27, 2017
Study Record Updates
Last Update Posted (Actual)
December 13, 2019
Last Update Submitted That Met QC Criteria
November 21, 2019
Last Verified
November 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CO-17-2437
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
Clinical Trials on EHR gaps
-
Boston University Charles River CampusMental Health Center of Denver; Connecticut State, Department of Mental Health... and other collaboratorsCompleted
-
Vanderbilt University Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedDiabetes MellitusUnited States
-
Children's National Research InstitutePatient-Centered Outcomes Research Institute; Louisiana Public Health InstituteNot yet recruitingCongenital Heart Disease | Comorbidities and Coexisting ConditionsUnited States
-
Angelica Perez FornosUniversity of Innsbruck / Department of MechatronicsCompletedHearing Loss | DeafnessSwitzerland
-
Medical University of South CarolinaSouth Carolina Clinical & Translational Research Institute (SCTR)Active, not recruitingTobacco Use DisorderUnited States
-
University of California, San FranciscoCompleted
-
Abramson Cancer Center at Penn MedicineEmerson Collective; Tennessee OncologyCompleted
-
NYU Langone HealthMassachusetts General Hospital; University of Pennsylvania; OhioHealthCompleted
-
Abramson Cancer Center at Penn MedicineCompletedOvarian Cancer | Genetic Predisposition to Disease | Breast Cancer Female | Hereditary Diseases | Gene Mutation-Related Cancer | Hereditary Breast and Ovarian Cancer | Hereditary Cancer SyndromeUnited States
-
University of California, San FranciscoNational Institute of General Medical Sciences (NIGMS)Not yet recruitingAcute Kidney Injury | Anesthesia | Surgery ComplicationsUnited States